Baker K M, Singer H A
Division of Research, Weis Center for Research, Geisinger Clinic, Danville, PA 17822.
Circ Res. 1988 May;62(5):896-904. doi: 10.1161/01.res.62.5.896.
Angiotensin II elicits a receptor-mediated positive inotropic response in cardiac tissue from most mammalian species by activating voltage-sensitive slow Ca2+ channels. In the guinea pig, we confirm there is no in vitro contractile force development in bioassay systems using isolated hearts or left atrial tissue in response to angiotensin peptides. However, 125I-angiotensin II binding sites that have the characteristics of a membrane receptor were identified in ventricular (myocardial) and atrial membrane preparations from guinea pigs. In ventricles, saturation-binding data yielded an optimal fit to a two-site model with a high-affinity site Kd1 = 3.6 +/- 0.7 nM and a low-affinity site Kd2 = 433 +/- 126 nM and binding capacities of 66 +/- 10 and 821 +/- 49 fmol/mg protein, respectively. In atria, saturation binding data yielded an optimal fit to a two-site model with a high-affinity site Kd1 = 1.6 nM and a low-affinity site Kd2 = 300 nM and capacities of 145 and 752 fmol/mg protein, respectively. The ventricular binding of 125I-angiotensin II was stimulated approximately twofold in the presence of the divalent cations calcium and magnesium (10 mM). Nonhydrolyzable analogues of guanosine triphosphate increased the dissociation rate of the bound 125I-angiotensin II and decreased hormone binding to the receptor at equilibrium. Competition for 125I-angiotensin II binding by an agonist-antagonist analogue series correlated with previous studies obtained in the rabbit, a mammal in which inotropic responses to angiotensin II were demonstrated. The data indicate the presence of angiotensin II myocardial and atrial receptors and a G-type coupling protein in guinea pig. Although this species lacks an inotropic response to angiotensin peptides, there is a dose-dependent increase in inositol-1-phosphate production in response to angiotensin II, and this response is blocked by the selective angiotensin II antagonist [Sar1,Ile8]angiotensin II.(ABSTRACT TRUNCATED AT 250 WORDS)
血管紧张素II通过激活电压敏感性慢钙通道,在大多数哺乳动物的心脏组织中引发受体介导的正性肌力反应。在豚鼠中,我们证实在使用离体心脏或左心房组织的生物测定系统中,血管紧张素肽不会引起体外收缩力的产生。然而,在豚鼠心室(心肌)和心房膜制剂中鉴定出了具有膜受体特征的125I-血管紧张素II结合位点。在心室中,饱和结合数据最适合双位点模型,高亲和力位点Kd1 = 3.6 +/- 0.7 nM,低亲和力位点Kd2 = 433 +/- 126 nM,结合容量分别为66 +/- 10和821 +/- 49 fmol/mg蛋白质。在心房中,饱和结合数据最适合双位点模型,高亲和力位点Kd1 = 1.6 nM,低亲和力位点Kd2 = 300 nM,容量分别为145和752 fmol/mg蛋白质。在二价阳离子钙和镁(10 mM)存在下,125I-血管紧张素II的心室结合增加约两倍。鸟苷三磷酸的不可水解类似物增加了结合的125I-血管紧张素II的解离速率,并在平衡时降低了激素与受体的结合。激动剂-拮抗剂类似物系列对125I-血管紧张素II结合的竞争与先前在兔中获得的研究相关,兔是一种对血管紧张素II有正性肌力反应的哺乳动物。数据表明豚鼠存在血管紧张素II心肌和心房受体以及G型偶联蛋白。尽管该物种对血管紧张素肽缺乏正性肌力反应,但对血管紧张素II的肌醇-1-磷酸产生呈剂量依赖性增加,并且该反应被选择性血管紧张素II拮抗剂[Sar1,Ile8]血管紧张素II阻断。(摘要截短于250字)